March 21, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, where is the ROI?
March 20, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, after new highs, old lows will follow
March 17, 2017
Flat open expected; RegMed Investors’ (RMi) pre-open indications, I needed a sector fix and got a temporary high
March 16, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, the union of confidence and nervousness
March 15, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, blinding uncertainty
March 14, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, value sustainability?
March 13, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, a sinkhole forms
March 10, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, will your portfolio be any safer post Q4/16 financial results?
March 9, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, I found Nemo
March 8, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, lows are surpassing highs
March 7, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, show me some real upside
March 6, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, what investors don’t know hurts them
March 3, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, in and out of favor
March 2, 2017
Flat open expected; RegMed Investors’ (RMi) pre-open indications, will it or won’t it
March 1, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, fast and loose travels share pricing
February 28, 2017
Flat open expected; RegMed Investors’ (RMi) pre-open indications, bet on more than volatility
February 27, 2017
Flat open expected; RegMed Investors’ (RMi) pre-open indications, earnings are an expletive descriptive
February 23, 2017
Flat to higher open expected; RegMed Investors’ (RMi) pre-open indications, we’re overdue for the oversold to become the overbought
February 22, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, what will make our sector investible?
February 21, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, searching for a direction
February 17, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, an acquired taste
February 16, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, sell the stretched pricing situations
February 15, 2017
Mixed open expected; RegMed Investors’ (RMi) pre-open indications, will the sector continue to rise?
February 14, 2017
Lower open expected; RegMed Investors’ (RMi) pre-open indications, I rather pricing gains but, be ready for some pain
February 13, 2017
Higher open expected; RegMed Investors’ (RMi) pre-open indications, don’t expect much …
1 hour 25 min ago
RMi pre-open: Respect a veteran with a simple thank you for service
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.